Results 71 to 80 of about 3,539 (240)

Two‐Stage Surgical Management of Anogenital Hidradenitis Suppurativa in Patients on Biologic Therapy: A Retrospective Case Series

open access: yesInternational Wound Journal, Volume 23, Issue 4, April 2026.
ABSTRACT Hidradenitis suppurativa is a chronic inflammatory skin disorder causing painful nodules, abscesses and scarring, with the anogenital region presenting particular functional and reconstructive challenges. Although biologic therapy is commonly used in moderate to severe disease, its limitations highlight the role of surgery in advanced cases ...
Nino Fuchs   +3 more
wiley   +1 more source

Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 658-669, April 2026.
Forty‐three HS specialists from 22 European countries reported adherence to HS guidelines and use of antibiotics before biologics despite limited efficacy and rapid relapse (49% within 1–3 months). Seventy‐nine per cent supported short‐term biologics for severe Hurley I disease.
Georgios Nikolakis   +41 more
wiley   +1 more source

Advances in Bioprinting to Model Immune‐Mediated Skin Diseases

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 9, 6 March 2026.
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández   +4 more
wiley   +1 more source

Introducing MCC-PS: a novel prognostic score for Merkel cell carcinoma

open access: yesFrontiers in Oncology
IntroductionMerkel cell carcinoma (MCC) is an aggressive skin cancer with a poor prognosis, which only improved with the introduction of immunotherapies. An MCC prediction model with high diagnostic accuracy is lacking.
Nessr Abu Rached   +10 more
doaj   +1 more source

Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal [PDF]

open access: yes, 2017
As part of its single technology appraisal (STA) process, the UK National Institute for Health and Care Excellence (NICE) invited the manufacturer of adalimumab (AbbVie) to submit evidence on the clinical effectiveness and cost effectiveness of ...
A Kimball   +21 more
core   +3 more sources

In vitro and ex vivo immunomodulatory effects of human placental mesenchymal stem cells in hidradenitis suppurativa

open access: yesFrontiers in Immunology
BackgroundHidradenitis suppurativa is a chronic inflammatory skin disease marked by immune dysregulation and elevated pro-inflammatory cytokines. While biologics like adalimumab target specific pathways, their limited efficacy highlights the need for ...
Vaiva Jariene   +16 more
doaj   +1 more source

Perfil bacteriológico en pacientes con acné [PDF]

open access: yes, 2019
El acné es un motivo frecuente de consulta en Atención primaria y en Dermatología, el conocimiento del perfil bacteriológico del mismo junto al microbioma puede conllevar una mejoría en la aproximación terapéutica al mismo.
Puente Barbé, Guillén Octavio
core  

ACTH pituitary adenomas: neurosurgical aspects [PDF]

open access: yes, 2002
We report our experience with 19 cases of ACTH secreting pituitary adenomas. They were microadenomas in 50% of the cases, coming with the typical picture of the Cushing syndrome.
Aguiar, Paulo Henrique   +3 more
core   +3 more sources

Chronic Venous Disease in Patients With Hidradenitis Suppurativa and Lymphedema: An Overlooked Problem

open access: yes
JEADV Clinical Practice, EarlyView.
Patricia Garbayo‐Salmons   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy